BIVALIRUDIN CIPLA 250 Milligram Pdr/Conc/Soln/Inj/Inf Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

bivalirudin cipla 250 milligram pdr/conc/soln/inj/inf

cipla (eu) limited - bivalirudin - pdr/conc/soln/inj/inf - 250 milligram - direct thrombin inhibitors

Angiox Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

angiox

the medicines company uk ltd - bivalirudin - acute coronary syndrome - antithrombotic agents - angiox is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (pci), including patients with st-segment-elevation myocardial infarction (stemi) undergoing primary pci.angiox is also indicated for the treatment of adult patients with unstable angina / non-st-segment-elevation myocardial infarction (ua / nstemi) planned for urgent or early intervention.angiox should be administered with aspirin and clopidogrel.

ANGIOMAX POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

angiomax powder for solution

sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

BIVALIRUDIN POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

bivalirudin powder for solution

sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

BIVALIRUDIN FOR INJECTION POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

bivalirudin for injection powder for solution

fresenius kabi canada ltd - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

Bivalirudin Accord Healthcare 250 mg inj./inf. sol. (pwdr., conc.) i.v. vial Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bivalirudin accord healthcare 250 mg inj./inf. sol. (pwdr., conc.) i.v. vial

accord healthcare b.v. - bivalirudin 250 mg - powder for concentrate for solution for injection/infusion - 250 mg - bivalirudin 250 mg - bivalirudin